Aurobindo Pharma gets six observations from US FDA for Hyderabad unit
US FDA had conducted an inspection at the company’s Unit III, a formulations manufacturing facility at Bachupally, Hyderabad
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Home » Latest Updates » Page 261
Browsing Category
Latest Updates
Piramal Enterprises partners with IPA
Piramal Enterprises and IPA jointly will organise Chemist Awareness Programmes in different locations across India and chemists…
Clarivate Analytics unveils ‘India Innovation: Trends’ report
Pharma contributed 15 per cent of the total patents published in the top 10 DWPI categories in India
Plant protein may protect against type II diabetes, meat eaters at greater risk: Study
Source of dietary protein may play a role in the risk of developing type-II diabetes
Rusan Pharma launches anti-tobacco/ smoking awareness campaign
2baconil associates with Kings XI Punjab as health partner
Glenmark gets tentative US FDA nod for anti-coagulant drug
The product is the generic version of Pradaxa capsules, 75 mg, 110 mg and 150 mg of Boehringer Ingelheim Pharmaceuticals
Alembic Pharma gets tentative US FDA nod for anti-depressant tabs
According to IMS, the tablets have an estimated market size of $340 million for 12 months to December 2016
Mergermarket releases global PMB trend report
Biotech was the largest subsector by value with 42 deals worth $38.8 billion
Orchid Pharma receives EIR from US FDA for Tamil Nadu plant
The report was issued based on the successful inspection of the formulation manufacturing facility at Irungattukottai
Jubilant Life raises Rs 100 cr by issue of commercial papers
The tenure of instrument is 63 days, Jubilant Life Sciences said in a BSE filing